Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Other Non Operating Income (2019 - 2025)

Biodesix's Other Non Operating Income history spans 7 years, with the latest figure at $46000.0 for Q4 2025.

  • For Q4 2025, Other Non Operating Income fell 85.67% year-over-year to $46000.0; the TTM value through Dec 2025 reached $604000.0, up 147.54%, while the annual FY2025 figure was $604000.0, 727.4% up from the prior year.
  • Other Non Operating Income reached $46000.0 in Q4 2025 per BDSX's latest filing, down from $409000.0 in the prior quarter.
  • In the past five years, Other Non Operating Income ranged from a high of $3.1 million in Q3 2021 to a low of -$3.6 million in Q4 2022.
  • Average Other Non Operating Income over 5 years is -$15750.0, with a median of $5000.0 recorded in 2021.
  • Peak YoY movement for Other Non Operating Income: crashed 45100.0% in 2022, then surged 18600.0% in 2024.
  • A 5-year view of Other Non Operating Income shows it stood at $8000.0 in 2021, then plummeted by 45100.0% to -$3.6 million in 2022, then skyrocketed by 100.06% to $2000.0 in 2023, then soared by 15950.0% to $321000.0 in 2024, then plummeted by 85.67% to $46000.0 in 2025.
  • Per Business Quant, the three most recent readings for BDSX's Other Non Operating Income are $46000.0 (Q4 2025), $409000.0 (Q3 2025), and $51000.0 (Q2 2025).